triple glp 1 agonist Effects, working principles and target tissues of dual agonists GLP-1-based therapies for type 2

Keratoconus diagnostic and treatment algorithms based on machine-learning methods

SURPASS-3 MRI, a sub-study of the phase-3 SURPASS-3 trial assessed tirzepatide administered once per week versus insulin degludec on liver fat content (LFC)

[DOI] [PubMed] [Google Scholar] 62.Holz GG, Leech CA, Heller RS, et al

Subsequently, we further verified that -catenin was significantly enriched in the nucleus in NTAPP-exposed hDP cells (Fig

Unlike conventional in vitro systems, which lack physiological complexity, or mammalian models, which are costly and low-throughput, zebrafish uniquely integrate experimental accessibility with in vivo relevance

Mario, G., Niso-Santano, M., Baehrecke, E